Literature DB >> 24899943

F-18 FDG PET Images of the Cervix at Various Time Points after the Loop Electrosurgical Excision Procedure.

Shin Young Jeong1, Jung-Joon Min2.   

Abstract

F-18 FDG PET is useful for monitoring residual or recurrent tumors after surgical resection. We describe five F-18 FDG PET images of three patients who had cervical carcinoma and then underwent a loop electrosurgical excision procedure (LEEP). Two of the images were taken within 15 days and three at least 2 months after LEEP. The earlier F-18 FDG PET images revealed linear hypermetabolic lesions in the cervix that were produced by inflammation. This was confirmed by pathological analysis. The later F-18 FDG PET images did not reveal any remarkable hypermetabolism in the cervix without any treatment. These observations suggest that, to determine the response to LEEP therapy, F-18 FDG PET should not be performed within 15 days of the procedure.

Entities:  

Keywords:  Cervical carcinoma; F-18 FDG PET; Loop electrosurgical excision procedure

Year:  2010        PMID: 24899943      PMCID: PMC4042971          DOI: 10.1007/s13139-009-0011-6

Source DB:  PubMed          Journal:  Nucl Med Mol Imaging        ISSN: 1869-3474


  10 in total

Review 1.  Management of cervical intraepithelial neoplasia.

Authors:  J T Cox
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

2.  Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.

Authors:  Sang-Young Ryu; Moon-Hong Kim; Suck-Chul Choi; Chang-Woon Choi; Kyung-Hee Lee
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

3.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.

Authors:  Lalitha K Shankar; John M Hoffman; Steve Bacharach; Michael M Graham; Joel Karp; Adriaan A Lammertsma; Steven Larson; David A Mankoff; Barry A Siegel; Annick Van den Abbeele; Jeffrey Yap; Daniel Sullivan
Journal:  J Nucl Med       Date:  2006-06       Impact factor: 10.057

4.  Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence.

Authors:  Hyun Hoon Chung; Hoenil Jo; Won Jun Kang; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; June-Key Chung; Soon-Beom Kang; Hyo-Pyo Lee
Journal:  Gynecol Oncol       Date:  2006-10-16       Impact factor: 5.482

5.  The role of hybrid PET/CT in the evaluation of patients with cervical cancer.

Authors:  Amnon Amit; Dan Beck; Lior Lowenstein; Offer Lavie; Rachel Bar Shalom; Zohar Kedar; Ora Israel
Journal:  Gynecol Oncol       Date:  2005-11-02       Impact factor: 5.482

6.  Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy.

Authors:  Tom R Miller; Perry W Grigsby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-06-01       Impact factor: 7.038

7.  Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer.

Authors:  Tzu-Chen Yen; Koon-Kwan Ng; Shih-Ya Ma; Hung-Hsueh Chou; Chien-Sheng Tsai; Swei Hsueh; Ting-Chang Chang; Ji-Hong Hong; Lai-Chu See; Wuu-Jyh Lin; Jenn-Tzong Chen; Kuan-Gen Huang; Kar-Wai Lui; Chyong-Huey Lai
Journal:  J Clin Oncol       Date:  2003-10-01       Impact factor: 44.544

Review 8.  Tools for post LEEP surveillance.

Authors:  Jacob Bornstein; Jacob Schwartz; Alexander Perri; Jefferey Harroch; Doron Zarfati
Journal:  Obstet Gynecol Surv       Date:  2004-09       Impact factor: 2.347

9.  The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival.

Authors:  Elizabeth A Kidd; Barry A Siegel; Farrokh Dehdashti; Perry W Grigsby
Journal:  Cancer       Date:  2007-10-15       Impact factor: 6.860

Review 10.  New trends in the evaluation and treatment of cervix cancer: the role of FDG-PET.

Authors:  Nicolas Magné; Cyrus Chargari; Lisa Vicenzi; Norman Gillion; Taha Messai; Jacques Magné; Gérald Bonardel; Christine Haie-Meder
Journal:  Cancer Treat Rev       Date:  2008-10-11       Impact factor: 12.111

  10 in total
  1 in total

1.  Endometrial Cancer with Cervical Extension Mimicking Dual Concordant Endometrial and Cervical Malignancy by F-18 FDG PET and MRI.

Authors:  Seok-Nam Yoon
Journal:  Nucl Med Mol Imaging       Date:  2012-06-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.